Donghua Zhang
Clinical trials sponsored by Donghua Zhang, explained in plain language.
-
New CAR-T therapy targets tough blood cancers
Disease control Recruiting nowThis study tests a new treatment called BAFFR CAR-T for people with B-cell blood cancers that have returned or not responded to standard therapy. About 28 to 30 adults aged 18 to 85 will receive this therapy to see if it is safe and helps them live longer. The approach uses the p…
Phase: NA • Sponsor: Donghua Zhang • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
Immune cell boost may keep leukemia at bay after transplant
Disease control Recruiting nowThis study tests whether giving patients special immune cells (γδ T cells) from a donor can help prevent their high-risk acute myeloid leukemia from returning after a stem cell transplant. About 40 adults aged 18 to 65 will receive the cell infusion and be monitored for safety an…
Phase: NA • Sponsor: Donghua Zhang • Aim: Disease control
Last updated May 22, 2026 13:51 UTC